StockNews.AI
PFE
benzinga.com
210 days

Legal Marijuana Linked To Drop In Anxiety Medications: What It Means For Pharma Giants - Roche Holding (OTC:RHHBY), Pfizer (NYSE:PFE)

1. Cannabis access reduces benzodiazepine prescriptions, impacting medication demand. 2. 23% of U.S. adults have mental health disorders; treatment rates are low. 3. FDA approved a trial for medical marijuana to treat PTSD in veterans. 4. Substituting cannabis for benzodiazepines may improve public health outcomes. 5. Pfizer's Xanax and Lorazepam could see declining sales due to cannabis alternatives.

5m saved
Insight
Article

FAQ

Why Bearish?

Decreased demand for benzodiazepines could negatively affect Pfizer's sales. Similar past trends showed impact on companies after alternative treatments emerged.

How important is it?

Findings suggest significant shifts in treatment practices that can impact Pfizer's bottom line. Increased cannabis use may diminish prescription revenues, reflecting a notable industry change.

Why Long Term?

The decline in prescriptions may persist as cannabis use rises. Historical cases show long-term shifts in opioid and benzodiazepine markets due to alternatives.

Related Companies

Related News